Abstract
Summary
Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.
LPI (LP Information)' newest research report, the “Neurological Disorder Diagnostics Industry Forecast” looks at past sales and reviews total world Neurological Disorder Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurological Disorder Diagnostics sales for 2023 through 2029. With Neurological Disorder Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disorder Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Neurological Disorder Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disorder Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disorder Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disorder Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disorder Diagnostics.
The global Neurological Disorder Diagnostics market size is projected to grow from US$ 9859.1 million in 2022 to US$ 13200 million in 2029; it is expected to grow at a CAGR of 4.3% from 2023 to 2029.
United States market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurological Disorder Diagnostics players cover Siemens, Philips, GE, Esaote, Masimo, Croton Healthcare and Neusoft, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disorder Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Imaging Techniques
In Vitro Diagnostics Techniques
Segmentation by application
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft
LPI (LP Information)' newest research report, the “Neurological Disorder Diagnostics Industry Forecast” looks at past sales and reviews total world Neurological Disorder Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurological Disorder Diagnostics sales for 2023 through 2029. With Neurological Disorder Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Disorder Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Neurological Disorder Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Disorder Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Disorder Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Disorder Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Disorder Diagnostics.
The global Neurological Disorder Diagnostics market size is projected to grow from US$ 9859.1 million in 2022 to US$ 13200 million in 2029; it is expected to grow at a CAGR of 4.3% from 2023 to 2029.
United States market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurological Disorder Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurological Disorder Diagnostics players cover Siemens, Philips, GE, Esaote, Masimo, Croton Healthcare and Neusoft, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Disorder Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Imaging Techniques
In Vitro Diagnostics Techniques
Segmentation by application
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurological Disorder Diagnostics Market Size 2018-2029
2.1.2 Neurological Disorder Diagnostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neurological Disorder Diagnostics Segment by Type
2.2.1 Imaging Techniques
2.2.2 In Vitro Diagnostics Techniques
2.3 Neurological Disorder Diagnostics Market Size by Type
2.3.1 Neurological Disorder Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Neurological Disorder Diagnostics Market Size Market Share by Type (2018-2023)
2.4 Neurological Disorder Diagnostics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Ambulatory Care Centers
2.5 Neurological Disorder Diagnostics Market Size by Application
2.5.1 Neurological Disorder Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Neurological Disorder Diagnostics Market Size Market Share by Application (2018-2023)
3 Neurological Disorder Diagnostics Market Size by Player
3.1 Neurological Disorder Diagnostics Market Size Market Share by Players
3.1.1 Global Neurological Disorder Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Neurological Disorder Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Neurological Disorder Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neurological Disorder Diagnostics by Regions
4.1 Neurological Disorder Diagnostics Market Size by Regions (2018-2023)
4.2 Americas Neurological Disorder Diagnostics Market Size Growth (2018-2023)
4.3 APAC Neurological Disorder Diagnostics Market Size Growth (2018-2023)
4.4 Europe Neurological Disorder Diagnostics Market Size Growth (2018-2023)
4.5 Middle East & Africa Neurological Disorder Diagnostics Market Size Growth (2018-2023)
5 Americas
5.1 Americas Neurological Disorder Diagnostics Market Size by Country (2018-2023)
5.2 Americas Neurological Disorder Diagnostics Market Size by Type (2018-2023)
5.3 Americas Neurological Disorder Diagnostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disorder Diagnostics Market Size by Region (2018-2023)
6.2 APAC Neurological Disorder Diagnostics Market Size by Type (2018-2023)
6.3 APAC Neurological Disorder Diagnostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neurological Disorder Diagnostics by Country (2018-2023)
7.2 Europe Neurological Disorder Diagnostics Market Size by Type (2018-2023)
7.3 Europe Neurological Disorder Diagnostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurological Disorder Diagnostics by Region (2018-2023)
8.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2018-2023)
8.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Neurological Disorder Diagnostics Market Forecast
10.1 Global Neurological Disorder Diagnostics Forecast by Regions (2024-2029)
10.1.1 Global Neurological Disorder Diagnostics Forecast by Regions (2024-2029)
10.1.2 Americas Neurological Disorder Diagnostics Forecast
10.1.3 APAC Neurological Disorder Diagnostics Forecast
10.1.4 Europe Neurological Disorder Diagnostics Forecast
10.1.5 Middle East & Africa Neurological Disorder Diagnostics Forecast
10.2 Americas Neurological Disorder Diagnostics Forecast by Country (2024-2029)
10.2.1 United States Neurological Disorder Diagnostics Market Forecast
10.2.2 Canada Neurological Disorder Diagnostics Market Forecast
10.2.3 Mexico Neurological Disorder Diagnostics Market Forecast
10.2.4 Brazil Neurological Disorder Diagnostics Market Forecast
10.3 APAC Neurological Disorder Diagnostics Forecast by Region (2024-2029)
10.3.1 China Neurological Disorder Diagnostics Market Forecast
10.3.2 Japan Neurological Disorder Diagnostics Market Forecast
10.3.3 Korea Neurological Disorder Diagnostics Market Forecast
10.3.4 Southeast Asia Neurological Disorder Diagnostics Market Forecast
10.3.5 India Neurological Disorder Diagnostics Market Forecast
10.3.6 Australia Neurological Disorder Diagnostics Market Forecast
10.4 Europe Neurological Disorder Diagnostics Forecast by Country (2024-2029)
10.4.1 Germany Neurological Disorder Diagnostics Market Forecast
10.4.2 France Neurological Disorder Diagnostics Market Forecast
10.4.3 UK Neurological Disorder Diagnostics Market Forecast
10.4.4 Italy Neurological Disorder Diagnostics Market Forecast
10.4.5 Russia Neurological Disorder Diagnostics Market Forecast
10.5 Middle East & Africa Neurological Disorder Diagnostics Forecast by Region (2024-2029)
10.5.1 Egypt Neurological Disorder Diagnostics Market Forecast
10.5.2 South Africa Neurological Disorder Diagnostics Market Forecast
10.5.3 Israel Neurological Disorder Diagnostics Market Forecast
10.5.4 Turkey Neurological Disorder Diagnostics Market Forecast
10.5.5 GCC Countries Neurological Disorder Diagnostics Market Forecast
10.6 Global Neurological Disorder Diagnostics Forecast by Type (2024-2029)
10.7 Global Neurological Disorder Diagnostics Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens Neurological Disorder Diagnostics Product Offered
11.1.3 Siemens Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 Philips
11.2.1 Philips Company Information
11.2.2 Philips Neurological Disorder Diagnostics Product Offered
11.2.3 Philips Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Philips Main Business Overview
11.2.5 Philips Latest Developments
11.3 GE
11.3.1 GE Company Information
11.3.2 GE Neurological Disorder Diagnostics Product Offered
11.3.3 GE Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GE Main Business Overview
11.3.5 GE Latest Developments
11.4 Esaote
11.4.1 Esaote Company Information
11.4.2 Esaote Neurological Disorder Diagnostics Product Offered
11.4.3 Esaote Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Esaote Main Business Overview
11.4.5 Esaote Latest Developments
11.5 Masimo
11.5.1 Masimo Company Information
11.5.2 Masimo Neurological Disorder Diagnostics Product Offered
11.5.3 Masimo Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Masimo Main Business Overview
11.5.5 Masimo Latest Developments
11.6 Croton Healthcare
11.6.1 Croton Healthcare Company Information
11.6.2 Croton Healthcare Neurological Disorder Diagnostics Product Offered
11.6.3 Croton Healthcare Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Croton Healthcare Main Business Overview
11.6.5 Croton Healthcare Latest Developments
11.7 Neusoft
11.7.1 Neusoft Company Information
11.7.2 Neusoft Neurological Disorder Diagnostics Product Offered
11.7.3 Neusoft Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Neusoft Main Business Overview
11.7.5 Neusoft Latest Developments
12 Research Findings and Conclusion